Abstract:The mammalian gastrointestinal tract is colonized with a majority of gut microbes, affecting host metabolism and homeostasis. Gut microbiota plays a vital role in nutrient exchange, signaling transduction between intestinal epithelial cells, and resistance to pathogen invasion. Gut microbiota is divided into mucus layer bacteria and intestinal lumen bacteria based on the colonization distribution. Akkermansia muciniphila (A. muciniphila) prefers to colonize in the intestinal mucus layer, and specifically degrades mucins to produce short-chain fatty acids, providing energy for the host and promoting colonization of the bacterium itself. Degradation of mucins prompts the host to compensate for the production of more mucins, thereby maintaining the dynamics of these proteins. In the intestinal micro-ecosystem, A. muciniphila is non-pathogenic, and its colonization with suitable abundance contributes to the development of immune system, thus promoting intestinal health. The mechanisms by which A. muciniphila bears a protective role in the host intestine are currently unclear. In this review, we summarize the microenvironment for the colonization of A. muciniphila, physiological characteristics and pathophysiological impact of A. muciniphila on intestinal diseases, such as irritable bowel syndrome, inflammatory bowel diseases, and intestinal tumors. We also provided updates for current studies on signals that A. muciniphila enhances intestinal barrier integrity and regulates immune response. Together, we conclude that A. muciniphila is a promising probiotic, which could be a microbial target for the treatment of multiple intestinal diseases.

Health and Disease:Akkermansia Muciniphila,the Shining Star of the Gut Flora

Akkermansia muciniphila: A promising probiotic against inflammation and metabolic disorders

Research Progress on Akkermansia Muciniphila in Human Intestine

Akkermansia muciniphila: a promising target for the therapy of metabolic syndrome and related diseases

Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases

Recent findings in Akkermansia muciniphila-regulated metabolism and its role in intestinal diseases

The Biofunction of Akkermansia Muciniphila in Intestinal-Related Diseases

Akkermansia Muciniphila is a Promising Probiotic

Akkermansia muciniphila plays critical roles in host health

Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome

[Advances of Akkermansia muciniphila in regulating host functions]

Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges

Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes

Akkermansia muciniphila : biology, microbial ecology, host interactions and therapeutic potential

Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems

Akkermansia muciniphila, an important link between dietary fiber and host health

A comprehensive update on the immunoregulatory mechanisms of Akkermansia muciniphila: insights into active ingredients, metabolites, and nutrient-driven modulation

Akkermansia muciniphila – multifunctional bacteria

The influence of Akkermansia muciniphila on intestinal barrier function

The potential role of Akkermansia muciniphila in liver health

Akkermansia muciniphila as a Next-Generation Probiotic in Modulating Human Metabolic Homeostasis and Disease Progression: A Role Mediated by Gut-Liver-Brain Axes?